CRESCITA THERAPEUTICS INC (CTX.CA) Stock News

Canada - Toronto Stock Exchange - TSX:CTX - CA2258471028 - Common Stock

0.445 CAD

-0.01 (-1.11%)

Last: 12/9/2025, 7:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

CTX.CA Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Crescita Therapeutics Inc.

Crescita Reports Third Quarter 2025 Results

4 months ago - By: Crescita Therapeutics Inc. - Mentions: OTC

Crescita Reports Second Quarter 2025 Results

6 months ago - By: Crescita Therapeutics Inc. - Mentions: OTC

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

7 months ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis®

7 months ago - By: Crescita Therapeutics Inc. - Mentions: OTC

Crescita Reports First Quarter 2025 Results

9 months ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Reports Q4 and Fiscal 2024 Results

a year ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Reports Third Quarter 2024 Results

a year ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Therapeutics Announces Approval of Normal Course Issuer Bid

a year ago - By: Crescita Therapeutics - Mentions: OTC

Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024

a year ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Reports Second Quarter 2024 Results

a year ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years

a year ago - By: Crescita Therapeutics - Mentions: OTC

Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement

a year ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device

a year ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Completes Acquisition of Strategic Assets of Occy Laboratory

1 years ago - By: Crescita Therapeutics - Mentions: OTC

Crescita to Acquire Strategic Assets of Occy Laboratory

2 years ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

2 years ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Reports First Quarter 2024 Results

2 years ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Reports Q4 and Fiscal 2023 Results

2 years ago - By: Crescita Therapeutics Inc. - Mentions: OTC

Crescita Reports Third Quarter 2023 Results

2 years ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Therapeutics Announces Approval of Normal Course Issuer Bid

2 years ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Reports Second Quarter 2023 Results

2 years ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

3 years ago - By: Crescita Therapeutics Inc. - Mentions: OTC

Crescita Reports First Quarter 2023 Results

3 years ago - By: Crescita Therapeutics Inc. - Mentions: OTC

Crescita Reports Q4 and Fiscal 2022 Results

3 years ago - By: Crescita Therapeutics Inc. - Mentions: OTC

Crescita Reports Third Quarter 2022 Results

3 years ago - By: Crescita Therapeutics Inc. - Mentions: OTC

Crescita Reports Second Quarter 2022 Results

4 years ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

4 years ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Reports First Quarter 2022 Results

4 years ago - By: Crescita Therapeutics - Mentions: OTC

Crescita to Present at Bloom Burton & Co. Healthcare Investor Conference

4 years ago - By: Crescita Therapeutics Inc. - Mentions: OTC

Crescita Reports Q4 and Fiscal 2021 Results

4 years ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Therapeutics Announces Renewal of Normal Course Issuer Bid

4 years ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis®

4 years ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Reports Third Quarter 2021 Results and Appoints New Board Member

4 years ago - By: Crescita Therapeutics - Mentions: OTC

Crescita Announces Exclusive Canadian Distribution Agreement with Obagi Cosmeceuticals LLC

4 years ago - By: Crescita Therapeutics Inc. - Mentions: OTC

Crescita Acquires Minority Interest in The Best You®

4 years ago - By: Crescita Therapeutics Inc. - Mentions: OTC

Crescita Therapeutics and STADA Enter 15-Country Exclusive Licensing Agreement for Pliaglis®

4 years ago - By: Crescita Therapeutics

Crescita Reports Second Quarter 2021 Results and Provides Corporate Update

4 years ago - By: Crescita Therapeutics Inc. - Mentions: OTC

Crescita Therapeutics Announces 9-Country Licensing Agreement with Croma Pharma for Pliaglis®